Literature DB >> 2981168

Defective monocyte function in patients with systemic lupus erythematosus.

R Phillips, R Lomnitzer, A A Wadee, A R Rabson.   

Abstract

Peripheral blood adherent cells from patients with systemic lupus erythematosus (SLE) were shown to have markedly reduced phagocytic activity as compared to normal adherent cells or those from non-SLE patients receiving corticosteroid therapy. Both resting and phagocytosing monocytes showed decreased hexose monophosphate shunt and glycolytic activity. Mononuclear cells from SLE patients showed grossly impaired proliferative activity after NaIO4 activation. Furthermore, addition of SLE adherent cells to normal adherent cell-depleted lymphocytes decreased [3H]thymidine incorporation of the latter cells following NaIO4 treatment. Addition of normal adherent cells to SLE lymphocytes corrected the previous defect, indicating that an adherent abnormality is responsible for the defect in SLE mononuclear cell proliferation to NaIO4 activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981168     DOI: 10.1016/0090-1229(85)90008-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.

Authors:  Zijun Wang; Hai Long; Christopher Chang; Ming Zhao; Qianjin Lu
Journal:  Cell Mol Life Sci       Date:  2018-07-04       Impact factor: 9.261

3.  Aberrant regulation of the integrin very late antigen-4 in systemic lupus erythematosus.

Authors:  H Rahimi; K Maurer; L Song; E Akhter; M Petri; K E Sullivan
Journal:  Lupus       Date:  2013-03       Impact factor: 2.911

4.  Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Authors:  S Sipka; K Szucs; S Szántó; I Kovács; G Lakos; E Kiss; P Antal-Szalmás; G Szegedi; P Gergely
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility.

Authors:  F Steinbach; F Henke; B Krause; B Thiele; G R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

Review 6.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

7.  In vitro effects of gold sodium thiomalate on IL-1, IL-2 production, IL-2 receptor expression and IL-2 responsiveness in thymocytes and peripheral blood mononuclear cells.

Authors:  E Blitstein-Willinger; A Streller
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

8.  Increased production of the third component of complement (C3) by monocytes from patients with systemic lupus erythematosus.

Authors:  H Tsukamoto; A Ueda; K Nagasawa; Y Tada; Y Niho
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

9.  Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro.

Authors:  A Mackiewicz; M Sobieska; M Kapciñska; S H Mackiewicz; K E Wiktorowicz; T Pawłowski
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

10.  Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus.

Authors:  W A Nockher; R Wigand; W Schoeppe; J E Scherberich
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.